BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1410882)

  • 1. [The glucagonoma syndrome. 3 new cases].
    Arnaud A; Fetissof F; Lorette G; Reigner J; Bertrand G; Lecomte P
    Rev Med Interne; 1992; 13(2):103-8. PubMed ID: 1410882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucagonoma as a tumor found by the therapist].
    Trubnikov GV; Drankovich EV
    Ter Arkh; 1998; 70(2):60-2. PubMed ID: 9551577
    [No Abstract]   [Full Text] [Related]  

  • 3. The glucagonoma syndrome.
    Wynick D; Hammond PJ; Bloom SR
    Clin Dermatol; 1993; 11(1):93-7. PubMed ID: 8339206
    [No Abstract]   [Full Text] [Related]  

  • 4. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
    El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
    Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 7. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
    Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
    Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucagonoma--somatostatinoma].
    Schusdziarra V
    Z Gastroenterol; 1999 Jun; Suppl 1():33-5. PubMed ID: 10444813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with long-standing skin lesions. Necrolytic migratory erythema.
    Netea RT; Erceg A; Pieters G; Hermus AR
    Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
    [No Abstract]   [Full Text] [Related]  

  • 10. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 11. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glucagonoma: evolution and treatment].
    Carvajal C; Azabache V; Lobos P; Ibarra A
    Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic spastic tetraparesis in glucagonoma syndrome. Successful therapy with octreotide, dacarbazine and interferon-alpha].
    Strohm WD
    Z Gastroenterol; 1996 Jul; 34(7):438-45. PubMed ID: 8928539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucogonoma syndrome].
    De Haas ER; Sanders CJ; Schermer FJ; Lips CJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1336-7. PubMed ID: 10454886
    [No Abstract]   [Full Text] [Related]  

  • 16. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
    Chaw L; Krop TM; Hood AF
    Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
    Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
    Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of glucagonoma. Value of scanning, echography and arteriography. Apropos of 2 cases and a review of the literature].
    Hercot O; Legmann P; Humbert M; Sibert A; Somveille E; Picard C; Mignon M; Benacerraf R
    J Radiol; 1989; 70(4):309-16. PubMed ID: 2552085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucagonoma syndrome: clinical features, diagnosis, and treatment.
    Stacpoole PW
    Endocr Rev; 1981; 2(3):347-61. PubMed ID: 6268399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant glucagonoma: an uncommon cause of new onset diabetes].
    Guerrero Vázquez R; Oliva Rodríguez R; Cuenca Cuenca JI; Sánchez Alberdi F; Navarro González E
    Endocrinol Nutr; 2011 Apr; 58(4):199-201. PubMed ID: 21334267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.